Shenzhen Beimei Pharmaceutical develops prescription medicines for children.
Established in 2010 and based in Shenzhen, China, Shenzhen Beimei Pharmaceutical focuses on pediatric prescription drugs and has a research and development and product introduction team. It works with pharmaceutical companies including Cipla, Hetero, DEVA Holding, EMP Pharma, LTS, and MedPharma. Its products address respiratory, neurological, infectious, dermatological, blood, digestive, immune, and endocrine conditions. In July 2023, it raised strategic investment from AOSAIKANG PHARM, Jiangsu Jinqiao Private Equity Fund Management, and Shenzhen Nanshan Strategic Emerging Industry Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in